Self-sampling tools to increase cancer screening among underserved patients: a pilot randomized controlled trial

被引:0
|
作者
Moss, Jennifer L. [1 ,2 ,8 ]
Entenman, Juliette [1 ]
Stoltzfus, Kelsey [1 ]
Liao, Jiangang [2 ]
Onega, Tracy [3 ,4 ]
Reiter, Paul L. [5 ]
Klesges, Lisa M. [6 ]
Garrow, George [7 ]
Ruffin, Mack T. [1 ]
机构
[1] Penn State Univ, Penn State Coll Med, Dept Family & Commun Med, Hershey, PA USA
[2] Penn State Univ, Penn State Coll Med, Dept Publ Hlth Sci, Hershey, PA USA
[3] Huntsman Canc Inst, Salt Lake City, UT USA
[4] Univ Utah, Sch Med, Dept Populat Hlth Sci, Salt Lake City, UT USA
[5] Ohio State Univ, Coll Publ Hlth, Dept Hlth Behav & Hlth Promot, Columbus, OH USA
[6] Washington Univ, Dept Surg, Sch Med St Louis, St Louis, MO USA
[7] Primary Hlth Network, Sharon, PA USA
[8] Penn State Univ, Penn State Coll Med, Dept Family & Commun Med, Dept Publ Hlth Sci, POB 855,MC A172,90 Hope Dr,2120E, Hershey, PA 17033 USA
基金
美国国家卫生研究院;
关键词
FACILITATORS; BARRIERS; WOMEN; PARTICIPATION; ACCEPTABILITY; DISPARITIES; POPULATION; PREVALENCE; BREAST; ROLES;
D O I
10.1093/jncics/pkad103
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Screening can reduce cancer mortality, but uptake is suboptimal and characterized by disparities. Home-based self-sampling can facilitate screening for colorectal cancer (with stool tests, eg, fecal immunochemical tests) and for cervical cancer (with self-collected human papillomavirus tests), especially among patients who face barriers to accessing health care. Additional data are needed on feasibility and potential effects of self-sampling tools for cancer screening among underserved patients.Methods: We conducted a pilot randomized controlled trial with patients (female, ages 50-65 years, out of date with colorectal and cervical cancer screening) recruited from federally qualified health centers in rural and racially segregated counties in Pennsylvania. Participants in the standard-of-care arm (n = 24) received screening reminder letters. Participants in the self-sampling arm (n = 24) received self-sampling tools for fecal immunochemical tests and human papillomavirus testing. We assessed uptake of screening (10-week follow-up), self-sampling screening outcomes, and psychosocial variables. Analyses used Fisher exact tests to assess the effect of study arm on outcomes.Results: Cancer screening was higher in the self-sampling arm than the standard-of-care arm (colorectal: 75% vs 13%, respectively, odds ratio = 31.32, 95% confidence interval = 5.20 to 289.33; cervical: 79% vs 8%, odds ratio = 72.03, 95% confidence interval = 9.15 to 1141.41). Among participants who returned the self-sampling tools, the prevalence of abnormal findings was 24% for colorectal and 18% for cervical cancer screening. Cancer screening knowledge was positively associated with uptake (P < .05).Conclusions: Self-sampling tools can increase colorectal and cervical cancer screening among unscreened, underserved patients. Increasing the use of self-sampling tools can improve primary care and cancer detection among underserved patients.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] HPV self-sampling among cervical cancer screening nonattenders: a feasibility study in Estonia
    Hallik, R.
    Innos, K.
    Janes, J.
    Veerus, P.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31
  • [42] A RCT of a community health worker intervention using HPV self-sampling to increase cervical cancer screening among minority populations
    Carrasquillo, Olveen
    Koru-Sengul, Tulay
    McCann, Sheila
    Amofah, Anthony
    Kobetz, Erin
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (11)
  • [43] Randomized controlled trial of decision support tools for patients and providers to increase breast cancer chemoprevention
    Crew, Katherine D.
    Bhatkhande, Gauri
    Silverman, Thomas
    Jones, Tarsha
    Mata, Jennie
    Guzman, Ashlee
    He, Ting
    Dimond, Jill
    Kukafka, Rita
    CANCER RESEARCH, 2021, 81 (04)
  • [44] The ESSAG-trial protocol: A randomized controlled trial evaluating the efficacy of offering a self-sampling kit by the GP to reach women underscreened in the routine cervical cancer screening program
    Gezels, Eva
    Arbyn, Marc
    Coursier, Patrick
    Devroey, Dirk
    Martens, Patrick
    Simoens, Cindy
    Vaes, Bert
    Van Herck, Koen
    Vankrunkelsven, Patrick
    Verhoeven, Veronique
    Willems, Sara
    CONTEMPORARY CLINICAL TRIALS, 2024, 144
  • [45] Vaginal self-sampling for HPV in the context of cervical cancer screening
    Springe, L.
    Kivite-Urtane, A.
    Poplavska, E.
    Zodzika, J.
    Berza, N.
    Bukova-Zideluna, A.
    Curkste, A.
    Parna, K.
    Uuskula, A.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [46] Worldwide use of HPV self-sampling for cervical cancer screening
    Serrano, B.
    Ibanez, R.
    Robles, C.
    Peremiquel-Trillas, P.
    de Sanjose, S.
    Bruni, L.
    PREVENTIVE MEDICINE, 2022, 154
  • [47] HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
    A Szarewski
    L Cadman
    D Mesher
    J Austin
    L Ashdown-Barr
    R Edwards
    D Lyons
    J Walker
    J Christison
    A Frater
    J Waller
    British Journal of Cancer, 2011, 104 : 915 - 920
  • [48] A Randomized Controlled Trial of Financial Incentives to Increase Colorectal Cancer Screening
    Mehta, Shivan J.
    Pepe, Rebecca S.
    Gabler, Nicole B.
    Kanneganti, Mounika
    Reitz, Catherine
    Saia, Chelsea
    Teel, Joseph
    Asch, David A.
    Volpp, Kevin G.
    Doubeni, Chyke A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S144 - S145
  • [49] HPV self-sampling as an alternative strategy in non-attenders for cervical screening - a randomised controlled trial
    Szarewski, A.
    Cadman, L.
    Mesher, D.
    Austin, J.
    Ashdown-Barr, L.
    Edwards, R.
    Lyons, D.
    Walker, J.
    Christison, J.
    Frater, A.
    Waller, J.
    BRITISH JOURNAL OF CANCER, 2011, 104 (06) : 915 - 920
  • [50] HPV Self-Sampling for Cervical Cancer Screening in Under-Screened Saskatchewan Populations: A Pilot Study
    Vink, Erin
    Antaya, Gabriella
    Hamula, Camille
    Holinaty, Carla
    Minion, Jessica
    Pond, Gregory R.
    McCrea, Sabryna
    Dwernychuk, Lynn
    Graham, Holly
    Broderick, Gordon
    Kinloch, Mary
    Broderick, Jennifer Brown
    CURRENT ONCOLOGY, 2024, 31 (08) : 4261 - 4269